PET and SPET tracers for mapping the cardiac nervous system.

Abstract:

:The human cardiac nervous system consists of a sympathetic and a parasympathetic branch with (-)-norepinephrine and acetylcholine as the respective endogenous neurotransmitters. Dysfunction of the cardiac nervous system is implicated in various types of cardiac disease, such as heart failure, myocardial infarction and diabetic autonomic neuropathy. In vivo assessment of the distribution and function of cardiac sympathetic and parasympathetic neurones with positron emission tomography (PET) and single-photon emission tomography (SPET) can be achieved by means of a number of carbon-11-, fluorine-18-, bromine-76- and iodine-123-labelled tracer molecules. Available tracers for mapping sympathetic neurones can be divided into radiolabelled catecholamines, such as 6-[18F]fluorodopamine, (-)-6-[18F]fluoronorepinephrine and (-)-[11C]epinephrine, and radiolabelled catecholamine analogues, such as [123I]meta-iodobenzylguanidine, [11C]meta-hydroxyephedrine, [18F]fluorometaraminol, [11C]phenylephrine and meta-[76Br]bromobenzylguanidine. Resistance to metabolism by monoamine oxidase and catechol-O-methyl transferase simplifies the myocardial kinetics of the second group. Both groups of compounds are excellent agents for an overall assessment of sympathetic innervation. Biomathematical modelling of tracer kinetics is complicated by the complexity of the steps governing neuronal uptake, retention and release of these agents as well as by their high neuronal affinity, which leads to partial flow dependence of uptake. Mapping of cardiac parasympathetic neurones is limited by a low density and focal distribution pattern of these neurones in myocardium. Available tracers are derivatives of vesamicol, a molecule that binds to a receptor associated with the vesicular acetylcholine transporter. Compounds like (-)-[18F]fluoroethoxybenzovesamicol display a high degree of non-specific binding in myocardium which restricts their utility for cardiac neuronal imaging.

authors

Langer O,Halldin C

doi

10.1007/s002590100640

subject

Has Abstract

pub_date

2002-03-01 00:00:00

pages

416-34

issue

3

eissn

1619-7070

issn

1619-7089

journal_volume

29

pub_type

杂志文章,评审
  • The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition.

    abstract:UNLABELLED:There are specific dose recommendations for diagnostic amyloid PET imaging with 18F-florbetapir, but they may not apply to research studies using regional quantitative analysis. We, therefore, studied the effect of tracer dose reduction on the discriminative power of regional analysis. METHODS:Using bootstr...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-014-2842-3

    authors: Herholz K,Evans R,Anton-Rodriguez J,Hinz R,Matthews JC

    更新日期:2014-11-01 00:00:00

  • Rationale for the use of radiolabelled peptides in diagnosis and therapy.

    abstract::Nuclear medicine techniques are becoming more important in imaging oncological and infectious diseases. For metabolic imaging of these diseases, antibody and peptide imaging are currently used. In recent years peptide imaging has become important, therefore the rationale for the use of peptide imaging is described in ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,评审

    doi:10.1007/s00259-011-2038-z

    authors: Koopmans KP,Glaudemans AW

    更新日期:2012-02-01 00:00:00

  • Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging.

    abstract::Medical imaging has made a major contribution to cerebral dysfunction due to inherited diseases, as well as injuries sustained with modern living, such as car accidents, falling down, and work-related injuries. These injuries, up until the introduction of sensitive techniques such as positron emission tomography (PET)...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,收录出版

    doi:10.1007/s00259-013-2401-3

    authors: Hayempour BJ,Alavi A

    更新日期:2013-09-01 00:00:00

  • [11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates.

    abstract:PURPOSE:Deposition of misfolded alpha-synuclein (αSYN) aggregates in the human brain is one of the major hallmarks of synucleinopathies. However, a target-specific tracer to detect pathological aggregates of αSYN remains lacking. Here, we report the development of a positron emission tomography (PET) tracer based on an...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-020-05133-x

    authors: Kuebler L,Buss S,Leonov A,Ryazanov S,Schmidt F,Maurer A,Weckbecker D,Landau AM,Lillethorup TP,Bleher D,Saw RS,Pichler BJ,Griesinger C,Giese A,Herfert K

    更新日期:2020-12-28 00:00:00

  • Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants.

    abstract:PURPOSE:To assess the binding of the PET tracer [18F]THK5351 in patients with different primary progressive aphasia (PPA) variants and its correlation with clinical deficits. The majority of patients with nonfluent variant (NFV) and logopenic variant (LV) PPA have underlying tauopathy of the frontotemporal lobar or Alz...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-018-4075-3

    authors: Schaeverbeke J,Evenepoel C,Declercq L,Gabel S,Meersmans K,Bruffaerts R,Adamczuk K,Dries E,Van Bouwel K,Sieben A,Pijnenburg Y,Peeters R,Bormans G,Van Laere K,Koole M,Dupont P,Vandenberghe R

    更新日期:2018-12-01 00:00:00

  • Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.

    abstract:PURPOSE:Preclinical, or asymptomatic, Alzheimer's disease (AD) refers to the presence of positive AD biomarkers in the absence of cognitive deficits. This research concept is being applied to define target populations for clinical drug development. In a prospective community-recruited cohort of cognitively intact older...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-015-3156-9

    authors: Adamczuk K,Schaeverbeke J,Nelissen N,Neyens V,Vandenbulcke M,Goffin K,Lilja J,Hilven K,Dupont P,Van Laere K,Vandenberghe R

    更新日期:2016-01-01 00:00:00

  • Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma.

    abstract:PURPOSE:FDG PET/CT is an excellent tool to detect melanoma metastases and also allows quantification of FDG uptake using standardized uptake value (SUV). The aim of this study was to prospectively investigate the potential prognostic value of SUV for disease-free survival (DFS) and disease-specific survival (DSS) for p...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-012-2182-0

    authors: Bastiaannet E,Hoekstra OS,de Jong JR,Brouwers AH,Suurmeijer AJ,Hoekstra HJ

    更新日期:2012-10-01 00:00:00

  • ¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.

    abstract:PURPOSE:This study evaluated the usefulness of the maximum standardized uptake value (SUVmax) as a measure of histologic response to neoadjuvant chemotherapy in patients with extremity osteosarcoma. The correlation between [(18) F]FDG PET SUVmax values and histologic response to preoperative chemotherapy was also asses...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-013-2344-8

    authors: Kong CB,Byun BH,Lim I,Choi CW,Lim SM,Song WS,Cho WH,Jeon DG,Koh JS,Yoo JY,Lee SY

    更新日期:2013-05-01 00:00:00

  • Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.

    abstract:PURPOSE:To explore the potential complementary value of PET/CT and dynamic contrast-enhanced MRI in predicting pathological response to neoadjuvant chemotherapy (NAC) of breast cancer and the dependency on breast cancer subtype. METHODS:We performed (18)F-FDG PET/CT and MRI examinations before and during NAC. The imag...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-014-2770-2

    authors: Pengel KE,Koolen BB,Loo CE,Vogel WV,Wesseling J,Lips EH,Rutgers EJ,Valdés Olmos RA,Vrancken Peeters MJ,Rodenhuis S,Gilhuijs KG

    更新日期:2014-08-01 00:00:00

  • Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.

    abstract:PURPOSE:The aim of the study was to estimate normal ranges and test-retest measures for various parameters characterising dopamine metabolism from a prolonged (18)F-dopa positron emission tomography (PET) measurement using a reference tissue model and compare their value for the detection of early Parkinson's disease (...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-011-1819-8

    authors: Oehme L,Perick M,Beuthien-Baumann B,Wolz M,Storch A,Löhle M,Herting B,Langner J,van den Hoff J,Reichmann H,Kotzerke J

    更新日期:2011-08-01 00:00:00

  • Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.

    abstract::Positron emission tomography (PET) has now gained a place in the management of patients with cancer, including those with Hodgkin's disease and non-Hodgkin's lymphoma. Restaging studies and those addressing the monitoring of response to treatment are especially in focus. Most of the knowledge gained has been achieved ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,评审

    doi:10.1007/s00259-003-1168-3

    authors: Visvikis D,Ell PJ

    更新日期:2003-06-01 00:00:00

  • (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.

    abstract:PURPOSE:We investigated the potential value of (11)C-acetate (ACT) PET/CT in characterizing multiple myeloma (MM) compared with (18)F-FDG PET/CT. Bone marrow histological and whole-body (WB) MRI findings served as the reference standards. METHODS:In this prospective study, 15 untreated MM patients (10 men and 5 women,...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-013-2520-x

    authors: Lin C,Ho CL,Ng SH,Wang PN,Huang Y,Lin YC,Tang TC,Tsai SF,Rahmouni A,Yen TC

    更新日期:2014-01-01 00:00:00

  • Performance evaluation of the new whole-body PET/CT scanner: Discovery ST.

    abstract::Characterisation of the physical performance of the new integrated PET/CT system Discovery ST (GE Medical Systems) has been performed following the NEMA NU 2-1994 (N-94) and the NEMA NU 2-2001 (N-01) standards in both 2D and 3D acquisition configuration. The Discovery ST combines a four or eight multi-slice helical CT...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-003-1444-2

    authors: Bettinardi V,Danna M,Savi A,Lecchi M,Castiglioni I,Gilardi MC,Bammer H,Lucignani G,Fazio F

    更新日期:2004-06-01 00:00:00

  • The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis.

    abstract:PURPOSE:To analyse the diagnostic value of (18)F-FDG PET and MRI for the evaluation of active lesions in paediatric Langerhans cell histiocytosis. METHODS:We compared 21 (18)F-FDG PET scans with 21 MRI scans (mean time interval 17 days) in 15 patients (11 male, 4 female, age range 4 months to 19 years) with biopsy-pro...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-012-2278-6

    authors: Mueller WP,Melzer HI,Schmid I,Coppenrath E,Bartenstein P,Pfluger T

    更新日期:2013-02-01 00:00:00

  • Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.

    abstract:PURPOSE:There are controversial debates if patients with Hürthle cell carcinoma, also known as oxyphilic or oncocytic cell follicular thyroid carcinoma, have a poorer outcome. In this study, we systematically evaluated the clinical outcome in a large patient cohort following thyroidectomy and initial I-131 radioactive ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-020-04952-2

    authors: Wenter V,Albert NL,Unterrainer M,Ahmaddy F,Ilhan H,Jellinek A,Knösel T,Bartenstein P,Spitzweg C,Lehner S,Todica A

    更新日期:2021-02-01 00:00:00

  • Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.

    abstract::(124)I-PET/CT has a high clinical potential in patients with differentiated thyroid cancer (DTC). Two aspects deserve special mention: staging of recurrent or residual disease and pretherapy dosimetry. Used in combination (124)I-PET and CT allows foci of highly specific (124)I uptake to be localized with a low radiati...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,评审

    doi:10.1007/s00259-011-1773-5

    authors: Freudenberg LS,Jentzen W,Stahl A,Bockisch A,Rosenbaum-Krumme SJ

    更新日期:2011-05-01 00:00:00

  • Correlation between combining 18F-FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer.

    abstract:PURPOSE:Our study intended to explore the association between combining 18F-FDG PET/CT metabolic parameters and other clinical features and anaplastic lymphoma kinase (ALK) or c-ros oncogene 1 (ROS1) fusion in non-small-cell lung cancer (NSCLC). METHODS:Eight hundred and six patients with wild-type epidermal growth fa...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-019-04652-6

    authors: Ruan M,Liu L,Wang L,Lei B,Sun X,Chang C,Shen Y,Xie W

    更新日期:2020-05-01 00:00:00

  • Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography.

    abstract::Functional imaging of small animals, such as mice and rats, using ultra-high resolution positron emission tomography (PET) and single-photon emission tomography (SPET), is becoming a valuable tool for studying animal models of human disease. While several studies have shown the utility of PET imaging in small animals,...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-002-0776-7

    authors: Acton PD,Choi SR,Plössl K,Kung HF

    更新日期:2002-05-01 00:00:00

  • Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT.

    abstract:PURPOSE:The effect of various doses of methylphenidate on the binding of [(123)I]iodobenzamide ([(123)I]IBZM) to the rat D(2) receptor was assessed using small animal SPECT. METHODS:D(2) receptor binding was measured at baseline and after pretreatment with various doses of methylphenidate. For baseline and methylpheni...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-010-1668-x

    authors: Nikolaus S,Antke C,Beu M,Kley K,Wirrwar A,Huston JP,Müller HW

    更新日期:2011-04-01 00:00:00

  • [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.

    abstract:PURPOSE:The aim of this study was to evaluate the clinical usefulness of [(11)C]choline positron emission tomography (PET)/CT in comparison with bone scintigraphy (BS) in detecting bone metastases (BM) of patients with biochemical progression after radical treatment for prostate cancer (PCa). METHODS:Seventy-eight con...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-011-1920-z

    authors: Picchio M,Spinapolice EG,Fallanca F,Crivellaro C,Giovacchini G,Gianolli L,Messa C

    更新日期:2012-01-01 00:00:00

  • PET-CT image co-registration in the thorax: influence of respiration.

    abstract::Because anatomical information on fluorine-18 fluorodeoxyglucose (FDG) whole-body positron emission tomography (PET) images is limited, combination with structural imaging is often important. In principle, software co-registration of PET and computed tomography (CT) data or dual-modality imaging using a combined PET-C...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-001-0710-4

    authors: Goerres GW,Kamel E,Heidelberg TN,Schwitter MR,Burger C,von Schulthess GK

    更新日期:2002-03-01 00:00:00

  • Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis.

    abstract:PURPOSE:This meta-analysis summarized the accuracy of stress myocardial perfusion scintigraphy (MPS) and stress echocardiography for the diagnosis of coronary artery disease (CAD) in patients with arterial hypertension. METHODS:We searched for studies in which stress MPS or stress echocardiography were performed to de...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,meta分析

    doi:10.1007/s00259-011-1891-0

    authors: Gargiulo P,Petretta M,Bruzzese D,Cuocolo A,Prastaro M,D'Amore C,Vassallo E,Savarese G,Marciano C,Paolillo S,Filardi PP

    更新日期:2011-11-01 00:00:00

  • Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.

    abstract:PURPOSE:The purpose of this study was to evaluate therapeutic response to neoadjuvant chemotherapy (NAC) and predict breast cancer recurrence using Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST). MATERIALS AND METHODS:Fifty-nine breast cancer patients underwent fluorodeoxyglucose-positron emi...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00259-018-4008-1

    authors: Kitajima K,Nakatani K,Yamaguchi K,Nakajo M,Tani A,Ishibashi M,Hosoya K,Morita T,Kinoshita T,Kaida H,Miyoshi Y

    更新日期:2018-09-01 00:00:00

  • Quantification of [(123)I]PE2I binding to dopamine transporters with SPET.

    abstract::The iodinated cocaine derivative [(123)I]PE2I is a new selective ligand for in vivo studies of the dopamine transporter (DAT) with single-photon emission tomography (SPET). The aim of the present study was to describe a method for accurate quantification of binding data following a bolus injection of [(123)I]PE2I. Six...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-001-0742-9

    authors: Pinborg LH,Videbaek C,Svarer C,Yndgaard S,Paulson OB,Knudsen GM

    更新日期:2002-05-01 00:00:00

  • Highlights of the Annual Congress of the European Association of Nuclear Medicine, Helsinki 2004, and a dash of horizon scanning.

    abstract::The Annual Congress of the European Association of Nuclear Medicine represents the major scientific and professional event in the field of nuclear medicine in Europe. Specialists from all allied professions meet to discuss the latest findings and discoveries. A very large industrial exhibition demonstrates the latest ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type:

    doi:10.1007/s00259-004-1720-9

    authors: Ell PJ,European Association of Nuclear Medicine.

    更新日期:2005-01-01 00:00:00

  • Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET.

    abstract:PURPOSE:Quantitative image reconstruction in positron emission tomography (PET) requires an accurate attenuation map of the object under study for the purpose of attenuation correction. Current dual-modality PET/CT systems offer significant advantages over stand-alone PET, including decreased overall scanning time and ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-006-0086-6

    authors: Ay MR,Zaidi H

    更新日期:2006-11-01 00:00:00

  • Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

    abstract:PURPOSE:We present our first clinical experience with O-(2-18F-fluoroethyl)-L-tyrosine (FET) PET in patients with high-grade glioma treated with various neurooncological therapies including tumour-treating fields (TTFields) for the differentiation of tumour progression from treatment-related changes. METHODS:We retros...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-018-3992-5

    authors: Ceccon G,Lazaridis L,Stoffels G,Rapp M,Weber M,Blau T,Lohmann P,Kebir S,Herrmann K,Fink GR,Langen KJ,Glas M,Galldiks N

    更新日期:2018-07-01 00:00:00

  • In vivo bioluminescence reporter gene imaging for the activation of neuronal differentiation induced by the neuronal activator neurogenin 1 (Ngn1) in neuronal precursor cells.

    abstract:PURPOSE:Facilitation of the ability of neuronal lineages derived from transplanted stem cells to differentiate is essential to improve the low efficacy of neuronal differentiation in stem cell therapy in vivo. Neurogenin 1 (Ngn1), a basic helix-loop-helix factor, has been used as an activator of neuronal differentiatio...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-013-2457-0

    authors: Oh HJ,Hwang DW,Youn H,Lee DS

    更新日期:2013-10-01 00:00:00

  • Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

    abstract::The last 25 years have seen major changes in the imaging investigation and subsequent management of patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL); accurate staging is vital for prognostication and treatment in both, and particularly in HD. The choice of imaging modality for staging depends on i...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,评审

    doi:10.1007/s00259-003-1159-4

    authors: Vinnicombe SJ,Reznek RH

    更新日期:2003-06-01 00:00:00

  • Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.

    abstract:PURPOSE:Our purpose was to examine the prognostic value of post-CRT PET based on the presence or absence of FDG-avid metastatic lymph node(s) and metabolic response of the primary tumor in patients with clinically node-positive ESCC treated with definitive chemoradiotherapy (dCRT). METHODS:We identified 108 eligible p...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-017-3901-3

    authors: Yap WK,Chang YC,Hsieh CH,Chao YK,Chen CC,Shih MC,Hung TM

    更新日期:2018-05-01 00:00:00